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We observed a striking sequence similarity between precursors for promagainin and procaerulein type I (excluding the 
caerulein pcptide region). Additional comparisons of the promagainin precursor with those of other procaeruleins, pro- 
xenopsin, and peptide-Gly-Leu-amide revealed that all possess one or more copies of a structurally similar spacer module, 
from which an amphiphilic spacer peptide is cleaved. Promagainin yields the magainins, spacer peptides with antimicro- 
bial activity; we suggest other spacer peptides may have similar activity. We propose that the genes for the four kinds 
of hormones were derived from a common ancestral gene through gene and exon duplications and that the procaerulein 
and proxenopsin genes are mosaic genes in which the original 3’-ends were replaced by exon shuffling. 
Promagainin; Procaerulein; Domain homology; Exon shuffling; Exon duplication; (Xenopus luevis) 
1. INTRODUCTION 
Many small peptides have been found in the 
secretions from amphibian cutaneous glands; some 
have been characterized as to pharmacological ac- 
tivities, but for most, biological roles are only sug- 
gested [1,2]. The determination of nucleotide 
sequences for several prohormones from Xenopus 
faevis, the African clawed frog, has made possible 
the correlation of a number of the small peptides 
with their precursors [l-3]. These include com- 
plete and partial gene sequences for precursors of 
procaeruleins [4] and cDNA sequences for the 
precursors of procaeruleins [3,5,6], proxenopsin 
[7] and the peptide-Gly-Leu-amide (PGLa) [8,9]. 
There is also evidence for a second proxenopsin 
gene [2,4]. Most recently the partial cDNA se- 
quence of the promagainin precursor was deter- 
mined [lo]. 
We find that the promagainin sequence 
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possesses an overall close similarity to the pro- 
caerulein type I precursor [6], excluding the 
carboxyl-terminal caerulein peptide. Furthermore, 
the precursors for proxenopsin (excluding the 
xenopsin peptide) and PGLa exhibit similarity to 
the amino-terminal regions of promagainin and 
procaerulein precursors. 
Heretofore, active peptides from amphibian 
skin secretions have been classified by their 
similarities to active peptides from mammals, 
other vertebrates, and some invertebrates. As 
evidence from recent studies [ 1,2,6] suggests and as 
our analyses show, this approach is inadequate to 
describe the relationships among the genes for 
these four kinds of prohormones. Comparison of 
the information from the protein and nucleic acid 
sequences of these prohormones creates a different 
picture; each possesses one or more copies of a 
structurally similar small domain. We propose that 
these prohormones should be grouped together on 
the basis of the type of domain that they all share. 
2. COMPUTER ANALYSES AND RESULTS 
We searched for sequences similar to the promagainin precur- 
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sor, using the FASTP program of Lipman and Pearson [I 11 and 
the Protein Sequence Database of the Protein Identification 
Resource (National Biomedical Research Foundation, 
Washington, DC). We found that three other kinds of frog pro- 
hormone precursors, those for caerulein, xenopsin and PGLa, 
obtained initial scores above 50 and higher optimized scores 
with promagainin. No other sequences in the database gave 
scores in this range. The highest initial and optimized scores 
were 123 and 209 for the match with the procaerulein type I 
precursor, and 93 and 124 for the match with the proxenopsin 
precursor; such scores are high enough to indicate a probable 
relationship [l 11. The match of the promagainin with the PGLa 
precursor got lower scores of 66 and 75. However, in a FASTP 
search of the PGLa precursor, it got initial and optimized scores 
of 177 and 177 (no gaps inserted) with the proxenopsin 
precursor. 
To visualize the extent of the regions of similarity among 
these prohormones, we generated dotmatrix graphic plots, us- 
ing the Mutation Data Matrix [12] with a minimum score of 20 
and a window size (segment length) of 20. This type of com- 
parison is especially useful for displaying duplicated regions in 
sequences, such as those in promagainin [lo] and procaerulein 
[3-61. Fig. 1 shows the plots of the promagainin precursor with 
the precursors of procaerulein type I, proxenopsin and PGLa; 
duplicated regions form the repeated short diagonals. In con- 
trast, the plot of the proxenopsin and PGLa precursors is a 
single complete diagonal line (not shown). In the plot of pro- 
magainin and procaerulein type I, the region representing the 
carboxyl-terminal 20 residues of the latter sequence (where the 
single caerulein peptide is found) shows no similarity to the pro- 
magainin sequence. 
We also compared the sequences of the precursors for pro- 
magainin and procaerulein type I with our program ALIGN 
[12], using a bias of 6, a gap penalty of 6, and 100 randomiza- 
tions. The alignment (see fig.2) was essentially the same as that 
from the FASTP search; however, we omitted from pro- 
caerulein the first five residues (of the signal peptide) and the 
carboxyl-terminal 18 residues (containing the caerulein pep- 
tide), which were unmatched in the search, in order to compare 
-I I 
1 I I II.1 I, I,, I1 I I 
Procaerulein type I 
sequences of approximately the same length. The ALIGN score 
was 13.9 standard deviation units (SD). The two sequences have 
38% identity and nearly 74% similarity. Most of the identities, 
aside from those in the signal peptide, are somewhat clustered 
in three areas, as are many of the conservative substitutions. 
The identities and similarities fall into three repeating regions of 
approx. 50 residues in both proteins (see also fig.1). We have 
constructed alignments showing the sequence similarities in the 
signal and propeptides (fig.3) and in the repeating regions 
(fig.4). Because of the very close resemblance of the first 21 
residues of the promagainin precursor fragment to the signal 
peptide and propeptide of the other prohormones, we assume 
that they correspond, that only the first five residues of the 
signal peptide are missing and that the cleavage site is after the 
first proline. As shown in fig.4, the precursors of proxenopsin 
and PGLa contain only one copy each of the repeating region 
[2,7,8]. The small regions consisting of the xenopsin and 
caerulein active peptides (with their processing sequences) are 
not, of course, included in the alignment (fig.4); the position of 
one of these regions in a sequence is indicated by a slash before 
or after a repeating region. 
3. DISCUSSION 
We have shown that extensive sequence 
similarities are present between the precursors for 
promagainin and three other kinds of prohor- 
mones from the African clawed frog. The results 
of our computer-assisted comparisons strongly 
support our proposal that these sequences had a 
common origin. The resemblance of the pro- 
magainin and procaerulein type I precursors is 
especially striking, as the protein sequences are 
also almost the same length, excluding the 
carboxyl-terminal caerulein peptide module (see 
fig.2). 
Proxenopsin PGLa 
Fig.1. Comparison of the promagainin precursor sequence with those of the precursors for procaerulein type I, proxenopsin and PGLa. 
The dotmatrix plots were generated using the Mutation Data Matrix with a minimum score of 20 and a window size of 20. Grid marks 
represent IO-residue lengths. The short diagonal lines represent the three repeats in the promagainin and procaerulein sequences. The 
extension of the top lefthand diagonal line in each plot indicates the similar signal peptides. 
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1 10 20 30 40 50 60 70 
Ml /FICSLIAVICANALPQPEASADEDMDEREVRGlGKFLHSAGKFGKAFVGElMKSKRDA-EAVGPEAFADQ 
Cl . . .LL,VlFl~LS,CP~S~~~GF~~~---~~D~~~LAS~~GK~L~A~LK~GAHLLGGAP~R~~ND~RR~~~~ 
71 80 90 100 110 120 130 140 
Ml D--LDEREVRGIGKFLHSAKKFGKAFVGElMNSKRDA-EAVGPEAFADE--DLDEREVRGlGKFLHSAKK 
::::: :: :: : : ::: : :: ::: : :: : : 
Cl DDDVNERDVRGFASFLGKALKAALKlGANMLGGTPQQREAEDDVNERDVRGFGSFLGKALK 
141 150 160 
Ml FGKAFVGEIMNSKRDA-EAVDDRRWVE 
:: : :: 
Cl AALKlGANALGGSPGQREANDERRFADi.. 
Total score = 1204, 6 breaks 
59 Identltles out of 157 possible matches between residues 
100 random runs 
Alignment score = 13.92 SD Standard devlation = 16.83 Mean = 969.78 
Fig.2. Alignments of corresponding regions of the promagainin (Ml) and procaerulein type I (Cl) precursors produced by the ALIGN 
program, using the Mutation Data Matrix with a bias of 6 and a gap penalty of 6. Identities between the sequences are indicated by 
paired dots. For the procaerulein sequence, the signal peptide cleavage site and intron locations are indicated by an arrow and triangles, 
respectively. 
These precursors can be thought of as composed 
of two or more kinds of modules, or domains, ar- 
ranged in a basically similar manner. Repeats of 
these modules, especially in procaeruleins, are ar- 
ranged to produce different combinations. This 
concept was proposed [4,6] to explain the variety 
of structures found in the family of procaerulein 
hormones, and perhaps also the structures of pro- 
xenopsin and PGLa precursors [4]; we are exten- 
ding it to include the promagainin precursor. 
In all of these precursors the amino-terminal 
module includes a signal peptide of 20 residues and 
a 6-residue propeptide (see fig.3). All also have at 
least one copy of a module in which a segment of 
22-27 predominantly hydrophobic residues, but 
containing several lysines, is bounded on each side 
by a short segment of mostly hydrophilic residues 
(see fig.4). This module, or domain, was termed a 
spacer region [ 1,2] or a spacer segment [4] and, in 
the case of procaeruleins, an intercaerulein seg- 
ment [5]. The central hydrophobic segment was 
called a spacer peptide [2]. The precursors of pro- 
xenopsin and PGLa have one copy of the spacer 
module [7,8], procaeruleins have two or more very 
similar copies [4-61, and promagainin has three 
nearly identical copies [lo]. Similarities among 
1 
12345678901234567890123456 2d 
1 PROMAGAININ /FICSLIAVICANALPQPEASA... 
2 PROXENOPSIN MYKGIFLCVLLAVICANSLATPSSDA... 
3 PGLa MYKQIFLCLIIAALCATIMAEASAFA... 
4 PROCAERULEIN 1 MFKGILLCVLFAVLSANPLSQPEGFA... 
Conserved MYKGIFLC L AV CAN L P A 
I I , 
Fig.3. Alignment of the amino ends of the four precursor sequences. Conserved residues are shown below the alignment; residues 
identical in all four sequences are marked. An arrow indicates the proposed cleavage site for the signal peptide; residues 21-26 form 
the proposed propeptide. 
284 
Volume 233, number 2 FEBS LETTERS June 1988 
1 2 3 4 6 
1234687890123466799012346878981234667990 
REPEAT 1 
Ml, 22-68 
+ 
. ..DEDYDEREVRCIGKFLHSAGKFGKAFVGEIMK-S~KRDAEAVGPEAFAD 
Cl, 27-71 . ..DE---ERDVRGLASFLGKALKAGLKIGAHLLGGAPQQREANDERRFAD 
C3, 27-71 . ..DE---ERDVRGLASLLGKALKAGLKIGTHFLGGAPQQREANDERRFAD/ 
C4, 27-71 . ..DE---ERDVRGLASLLGKALKAALKIGTHFLGGAPQQREANDERRFAD/ 
Xl, 27-73 . ..DEDNDEVERYVRGWASKIGQTLGKIAKVGLKELIQPK~REAMLRSAEA/ 
P1,27-64...DADEDDDKRYVRGMASKAGAIAGKIAKVALKALG~--RRDS---------- 
REPEAT 2 
Ml, 69-114 Q-DLDEREVRGIGKFLHSAKKFGKAFVGEI~N-S~KRDAEAVGPEAFAD 
Cl, 72-120 PDDDVNERDVRGFASFLGKALKAALKICANULCGTP99REANDERRFAD 
C4, 102-160 I /~EDDVHERDVRGFGSFLGKALKAALKICANALOCAPqqREANDERRFAD/ 
REPEAT 3 
Ml, 116-160 E-DLDEREVRGIGKFLHSAKKFGKAFVGEI~N-S~KRDAEAVDDRRWVE 
Cl, 121-169 PEDDVNERDVRGFGSFLGKALKAALKICANALCCSPqqREANDERRFAD/ 
C3, 102-160 /~EDDVNERDVRGFGSFLGKALKAALKICANALGOAPqqREANDERRFAD/ 
C4, 166-214 I /~EDDVNERDVRGFGSFLGKALKAALKICANALCOSPqqREANDERRFAD/ 
C0m0ll D R VRG 
Alter- DDEDVDE D FGSFLGKALKAALKIGANALGGSPQQREANDERRFAD 
mtiv** EED--NK E IAKLIHSTKGFhKAFVGEIYN -AKRDAYLVGPEA--- 
AQ- L- Y L KA PIG KIA VATHF KQPR ES--RSA--WVE 
N MV W A A LKL I - - _ _ 
EH M E T D 
D M 
Fig.4. Alignment of spacer modules from promagainin (Ml), procaerulein type I (Cl), procaerulein type III (C3). procaerulein type 
IV (C4), proxenopsin (Xl) and PGLa (PI). Residue numbers for the sequence segments are shown also. Common and alternative 
residues are shown below the alignment. The arrow between positions 12 and 13 indicates a common amino-terminal cleavage site for 
the hydrophobic segments (i.e., magainins and equivalents); carboxyl-ends are marked by vertical bars (see text). lntron positions in 
procaerulein sequences are represented by triangles; all are between the first and second nucleotide in the codon (see text). 
most of these spacer peptides have also been The central hydrophobic segments of the spacer 
pointed out by others [1,2,7,13,14], although the modules from these prohormones have been 
overall high degree of similarity between the pro- studied by Williams and co-workers [1,2] and by 
magainin and procaerulein precursors was not Kreil and co-workers [6,9]. These segments have 
recognized. In addition, the sequence around the been found as free peptides in the skin secretions 
Arg-Gly cleavage site (positions 12-13 in the fig.4 of the frog. It was proposed that the segments 
alignment) is highly conserved in all modules, not could form amphipathic helices and have potential 
only in the procaerulein modules [6], and may membrane-crossing capability and that secondary 
form the recognition site for a specific proteinase cleavages before lysine residues could affect activi- 
[6,9]. In the partially sequenced genes for pro- ty (e.g., deactivating a previously active peptide). 
caerulein precursors [4], each spacer module is en- Although no function was established for any of 
coded by two exons, except that the signal and these peptides, the degree of sequence similarity 
propeptide are also part of exon 2 (the first suggested that the peptides would,also show func- 
protein-coding exon). Positions of the introns, all tional similarity. The antimicrobial activity 
of which fall between the first and second reported for natural and synthetic magainin pep- 
nucleotide in a codon and so are phase 1 introns in tides [10,16], which form the central hydrophobic 
Patthy’s [15] classification, are indicated in figs 2 segment of the spacer modules in promagainin, 
and 4. We predict that phase 1 introns will be supports the possibility of similar activity for the 
found in corresponding positions in the genes of other peptides. Although the magainins do not 
the three other precursors. have a direct lytic effect, they disturb normal mem- 
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brane function(s) by an as yet undefined 
mechanism that appears to be dependent on 
membrane-crossing capability; removal of four to 
six amino-terminal residues resulted in loss of ac- 
tivity, presumably because the peptide was too 
short to form a membrane-spanning helix [16]. 
A third type of module, or domain, consists of 
a neuroactive peptide sequence framed by short 
processing sequences; this type of module is seen 
only in the proxenopsin [7,17] and procaerulein 
precursors [4-6,181. One to many copies of this 
type of module may be present. If one copy (as in 
proxenopsin), it is located at the carboxyl-end of 
the precursor, and if more than one (as in most 
procaeruleins), they are interspersed with the 
spacer modules and may be doubled [4,5]. The 
gene for the type I procaerulein precursor was 
found to contain a potential caerulein exon, lying 
between the exons encoding spacer modules 1 and 
2, as well as a partial caerulein exon following the 
exons for spacer module 2 [4]. It was proposed that 
the arrangements of the different types of modules 
observed in the various procaerulein genes is the 
result of a combination of genetic events [4]. 
Originally there was a simple gene composed of a 
5 ‘-noncoding exon, an exon coding for a signal 
peptide, propeptide and part of a spacer region, an 
El E2 E3 
exon for the rest of the spacer region, an exon for 
the caerulein peptide (with processing sequences) 
and the 3’-noncoding region, and three introns. 
The first event was a duplication of most of this 
simple gene including introns starting midway 
through the second exon. Subsequently, other 
mechanisms, such as deletion or nonexpression of 
exons, duplication of single exons, duplication of 
entire genes, and possibly gene conversion events, 
produced the family of procaerulein genes now 
observed [4]. 
Although the active peptides contained in the 
third type of module may be related to various 
mammalian active peptides (e.g., caerulein to 
gastrin and cholecystokinin, and xenopsin perhaps 
to neurotensin), as well as to cholecystokinin-like 
or neurotensin-like peptides in other tissues of the 
frog [2,19], there is no similarity between the se- 
quences of the spacer modules and the remainder 
(the amino-end) of the sequences of the mam- 
malian hormone precursors [ 1,3,6]. However, 
there is similarity of gene structure in that the 
genes for the precursors of procaeruleins and pro- 
xenopsin [4], for human progastrin [20-221 and 
for rat procholecystokinin [23,24] all appear to 
have only phase 1 introns [15]. We assume that the 
amphibian genes for cholecystokinin-like and 
A 5’ NC S ;Pi 3’ NC 
El E2 E3 E4 E5 E6 E7 
Ml M2 M3 
El E2 E3 E4 
C 5’ NC S ;pj 3’ NC I 
El E2 E3 E4 ES E6 E7 E6 
D 5’ NC S ;P/ SPA CEA c j 3’ NC 
Fig.5. Diagram of proposed exon-intron arrangement in an ancestral gene compared with suggested arrangements in the prohormone 
genes. (A) Ancestral gene and possibly PGLa precursor gene. (B) Promagainin precursor gene. (C) Proxenopsin precursor gene. (D) 
Procaerulein (type 1) precursor gene. Intron positions (exon boundaries) are marked by wide solid vertical lines; the boundary between 
signal peptide and propeptide is indicated by a dotted line, and other domain boundaries are indicated by dashed lines. Symbols for 
features are as follows: exons, El, E2, etc.; 5 ’ -noncoding region, 5’ NC; 3 ’ -noncoding region, 3 ’ NC; signal peptide, S: propeptide, 
P; magainin peptides, Ml, M2, M3; xenopsin peptide module, X; caerulein peptide module, C. 
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neurotensin-like proteins also have phase 1 in- 
trons. This type of gene structure, in which all in- 
trons have the same phase class, is correlated with 
exon shuffling (including exchange between 
originally nonhomologous genes) and exon 
duplication in gene assembly, according to Patthy 
1151. 
As striking as the protein sequence similarity is, 
the relationship between the promagainin and pro- 
caerulein type I precursors is most likely indirect 
rather than direct. The near identity of the 
repeated spacer modules within each sequence, as 
opposed to over 60% difference between the two, 
argues for an independent development of the 
repetitive structure from a smaller ancestral gene. 
We envision this ancestral gene, from which the 
four kinds of prohormones were derived, as having 
several exons corresponding to the 5 ’ -noncoding 
region, the signal peptide and propeptide plus part 
of the spacer module, the remainder of the spacer 
module and the 3 ’ -noncoding region (see fig.5). 
Duplications produced several copies of the entire 
gene before the different prohormones evolved. 
The gene for the PGLa precursor may retain this 
basic form. Subsequent duplications of the exons 
encoding the spacer module could produce a gene 
encoding a protein like the promagainin precursor 
(see fig.5). On the other hand, the evidence in- 
dicates that the proxenopsin and procaerulein 
precursors are encoded by mosaic genes produced 
by exon shuffling with two other kinds of genes. 
The 3 ‘-end of the original gene was replaced in 
each by an exon, for a neuroactive peptide module 
and a 3 ’ -noncoding region, derived from the 
3 ‘-end of another hormone gene in the frog’s 
genome (see fig.5). For example, by this process 
the simple procaerulein gene described by Vlasak 
et al. [4] would have derived its 3 ‘-exon from a 
cholecystokinin-like or gastrin-like gene; duplica- 
tions and other genetic mechanisms would produce 
the various procaerulein precursors [4]. In our 
view the exon shuffling events are superimposed 
(in the genes for proxenopsins and procaeruleins) 
on a gene structure common to all four kinds of 
prohormones; thus the four are basically 
homologous. Furthermore, the homologous spacer 
domains in the four kinds of prohormones are pro- 
cessed to release similar peptides; the magainin 
peptides were shown to have antimicrobial activity 
[10,16], so it is probable that all these spacer pep- 
tides will have functional as well as structural 
similarity. 
ADDENDUM 
After submission of this paper we learned of the 
contribution of Soravia et al. 1251, which 
demonstrates that the amphiphilic spacers, iden- 
tified here as analogs of magainin, have an- 
timicrobial activity. 
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